0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Adverse Drug Effects
 41-60 of 176 Articles
Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(6):560-561. doi:10.1001/jama.2014.481.

Medical News & Perspectives | 
Mike Mitka, MSJ
JAMA. 2014;311(5):454-455. doi:10.1001/jama.2013.285786.

Editorial |  FREE
Eric D. Peterson, MD, MPH; J. Michael Gaziano, MD; Philip Greenland, MD
JAMA. 2014;311(5):474-476. doi:10.1001/jama.2013.284430.

JAMA Revisited | 
JAMA. 2014;311(4):423. doi:10.1001/jama.2013.279299.

Clinical Trials Update | 
Anita Slomski
JAMA. 2014;311(4):349. doi:10.1001/jama.2014.61.

Original Investigation |  FREE
Leonard V. Sacks, MBBCh; Hala H. Shamsuddin, MD; Yuliya I. Yasinskaya, MD; et al.
JAMA. 2014;311(4):378-384. doi:10.1001/jama.2013.282542.
Includes: CME, Supplemental Content

JAMA Patient Page |  FREE
Jill Jin, MD, MPH
JAMA. 2014;311(3):321. doi:10.1001/jama.2013.283505.
Includes: Supplemental Content

Original Investigation |  FREE
Stephen J. Nicholls, MBBS, PhD; John J. P. Kastelein, MD, PhD; Gregory G. Schwartz, MD, PhD; et al.
JAMA. 2014;311(3):252-262. doi:10.1001/jama.2013.282836.
Includes: Supplemental Content

Original Investigation |  FREE
Sonja Gandhi, BSc; Jamie L. Fleet, BHSc; David G. Bailey, BScPhm, PhD; et al.
JAMA. 2013;310(23):2544-2553. doi:10.1001/jama.2013.282426.
Includes: Supplemental Content

Original Investigation |  FREE
Jameson R. Lam, MPH; Jennifer L. Schneider, MPH; Wei Zhao, MPH; et al.
JAMA. 2013;310(22):2435-2442. doi:10.1001/jama.2013.280490.
Includes: Supplemental Content

JAMA Clinical Challenge | 
Liran Levin, DMD; Liat Luder, RDH
JAMA. 2013;310(20):2195-2196. doi:10.1001/jama.2013.282405.

Editorial | 
Allan S. Brett, MD
JAMA. 2013;310(20):2151-2153. doi:10.1001/jama.2013.280501.

Clinical Trials Update | 
Anita Slomski
JAMA. 2013;310(20):2139. doi:10.1001/jama.2013.282477.

Original Investigation |  FREE
Björn Pasternak, MD, PhD; Henrik Svanström, MSc; Mads Melbye, MD, DrMedSci; et al.
JAMA. 2013;310(20):2184-2190. doi:10.1001/jama.2013.280500.
Includes: Supplemental Content

Editorial | 
Anne R. Cappola, MD, ScM
JAMA. 2013;310(17):1805-1806. doi:10.1001/jama.2013.280387.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2013;310(17):1784. doi:10.1001/jama.2013.281868.

Original Investigation |  FREE
Rebecca Vigen, MD, MSCS; Colin I. O’Donnell, MS; Anna E. Barón, PhD; et al.
JAMA. 2013;310(17):1829-1836. doi:10.1001/jama.2013.280386.
Includes: Supplemental Content

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2013;310(16):1666. doi:10.1001/jama.2013.281116.

Comment & Response | 
Russell K. Portenoy, MD
JAMA. 2013;310(16):1738. doi:10.1001/jama.2013.277291.

Comment & Response | 
Marcin Chwistek, MD
JAMA. 2013;310(16):1737. doi:10.1001/jama.2013.277305.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Brief Report  | 
Transient Macular Edema After Intracameral Injection of a Moderately Elevated Dose of Cefuroxime During Phacoemulsification Surgery
David C. Wong, MD; Michael D. Waxman, MD; Lisa J. Herrinton, PhD; et al.
JAMA Oncology
JAMA Oncology Clinical Challenge  | 
Melanoma and a Headache
Douglas B. Johnson, MD, MSCI; Tejaswi V. Mudigonda, BS; Jeffrey A. Sosman, MD
JAMA Dermatology
Original Investigation  | 
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Martina Sanlorenzo, MD; Igor Vujic, MD; Adil Daud, MD; et al.
JAMA Internal Medicine
Research Letter  | 
Drug Manufacturers’ Delayed Disclosure of Serious and Unexpected Adverse Events to the US Food and Drug Administration
Paul Ma, PhD; Iván Marinovic, PhD; Pinar Karaca-Mandic, PhD